Our study was a collaboration between investigators for 13 population-based incidence studies identified through a previous systematic review, 1 and our research networks. To understand how representative these studies were of all possible studies we undertook a systematic literature search of the literature published after the aforementioned systematic review, as detailed below.
Embase (n=721) (1) 'population-based' OR 'community-based' OR 'community' OR 'epidemiology' OR 'epidemiological' OR 'incidence' OR 'attack rates' OR 'survey' OR 'surveillance' OR 'ideal study' OR 'mortality' OR 'morbidity' OR 'fatality' OR 'case fatality' OR 'trends' OR 'population-based' OR 'community-based' OR 'community' OR 'epidemiology' OR 'epidemiological' OR 'incidence' OR 'attack rates' OR 'survey' OR 'surveillance' (2) 'stroke' OR 'ischaemic stroke' OR 'ischemic stroke' OR 'intracerebral' OR 'intraparenchymal' OR 'subarachnoid' OR 'haemorrhage' OR 'hemorrhage' OR 'ischemic stroke' AND .tw (3) #1 
Scopus (n=1966)
Search (TITLE ( "population-based" OR "community-based" OR "community" OR "epidemiology" OR "epidemiological" OR "incidence" OR "attack rates" OR "survey" OR "surveillance" OR "mortality" OR "morbidity" OR "fatality" OR "case fatality" OR "trends" ) ) AND ( TITLE ( "stroke" OR "ischaemic stroke" OR "ischemic stroke" OR "intracerebral" OR "intraparenchymal" OR "subarachnoid" OR "haemorrhage" OR hemorrhage ) ) AND ( LIMIT- 
ScienceDirect (n=811)
Limitation: pub-date > 2007 and pub-date < 2015 and TITLE ( "stroke" OR "ischaemic stroke" OR "ischemic stroke" OR "intracerebral" OR "intraparenchymal" OR "subarachnoid" OR "haemorrhage" OR hemorrhage OR "ischemic stroke" ) AND TITLE ( "mortality" OR "morbidity" OR "fatality" OR "case fatality" OR "trends" OR "population-based" OR "community-based" OR "community" OR "epidemiology" OR "epidemiological" OR "incidence" OR "attack rates" OR "survey" OR "surveillance")
Data collection
Authors of each eligible study were contacted with a request for de-identified individual participant data (IPD) on stroke outcomes up to 5 years after stroke. Outcomes included mortality (date, time of stroke, date of death), functional outcomes and health-related quality of life. Data on participant characteristics were requested if available including socio-demographics (age, sex, marital status, education, occupation, socioeconomic position), pre-stroke health including body mass index, health behaviors (smoking, alcohol use), pre-stroke function (dependency, institutional residence), pre-stroke medication, history of comorbidities (atrial fibrillation, hypertension, ischemic heart disease, peripheral vascular disease, transient ischemic attack, diabetes, dementia), stroke-related factors (stroke severity, stroke type, the year of stroke occurrence), treatment and management (hospital admission, time to hospital, admission and discharge medication, neuroimaging, carotid investigation, echocardiography and surgical intervention) and post-stroke factors (depression and recurrence). Data provided were checked again with published data, where possible, and if discrepancies were identified, clarification was sought from authors. When no response was provided to data requests or no response from authors, we checked whether results of sex differences were reported in published papers.
Data management
Study-specific outcomes and variable definitions (i.e. covariates) were recorded and, where necessary, recoded to create common variables with consistent definitions (e.g. stroke severity). Following recoding, 13 datasets were then merged into one common database using study identification numbers.
Data S2.
Measurement of potential confounding factors of sex difference in NIHSS of stroke at acute stroke
Socio-demographics
Data on age at the index stroke were available in all studies without age restriction. Race data from studies in Melbourne and Matão were categorised as Caucasian/Non-Caucasian. Educational level (studies conducted in Oxford, Joinville, Melbourne and Matão) was divided into two groups with the cut-off point of completing secondary education (grade 12). Classification of socioeconomic position (SEP) includes three groups: professional / non-manual (skilled + unskilled) / manual (skilled + unskilled) in 4 studies (Oxford, Melbourne, and Perth). Data on marital status (Oxford, Perth, Orebro and Matão) were categorized into 2 group: married / unmarried (including single, divorced, and widowed).
Pre-stroke health

Co-morbidities
Analysis of binary data of self-reported history of diabetes (4 studies: Oxford, Melbourne, Perth and Orebro), dementia (3 studies Melbourne, Orebro and Matão), and cardiovascular diseases including ischaemic heart disease (all studies), atrial fibrillation (all studies), hypertension (all studies), transient ischaemic attack (all studies), and peripheral vascular disease (5 studies: Oxford, Melbourne, Orebro, Dijon and Matão) were performed.
Body mass index (BMI) was recorded in 5 studies including Oxford, Joinville, Perth, Martinique and Porto.
Pre-stroke medication
Data on pre-stroke use of antihypertensive and antiplatelet agents were available in 5 studies (Joinville, Melbourne, Perth, Auckland and Tartu) and information on use of anticoagulants before stroke was only available in 2 studies (Melbourne and Auckland).
Smoking and alcohol use
Smoking status, which was recorded in 7 studies (not including Tartu), was categorized into 3 levels: never / former / current. Data on alcohol consumption were available in 6 studies. Alcohol use was analysed as 3 groups -no / current drinkers / ex-drinkers in 3 studies (Perth, Dijon, Matão) or 4 groups -no / not heavy drinkers / heavy drinkers / ex-drinkers in 3 studies (Oxford, Melbourne and Auckland) which depend on available data within different studies.
Pre-stroke dependency
Pre-stroke functional status was assessed according to residing in an institution before stroke in 4 studies (Melbourne, Perth, Orebro and Dijon), the pre-stroke Barthel Index in 3 studies (Melbourne, Perth and Orebro) or pre-stroke modified Rankin Score (mRS) in 4 studies (Oxford, Perth and Tartu). Pre-stroke dependency was defined as pre-stroke Barthel <20 or pre-stroke mRS>2.
Management at acute stroke
Hospital admission
Data on whether the patient was admitted to hospital were available in all studies.
Delay to hospital
Analyses of these data were based on the time from stroke onset to admission time. Among 3 studies with these data (Oxford, Perth and Tartu), we calculated the time to hospital from time of stroke onset to time of admission and then categorized into them three groups (≤4.5 hours / 4.5 hours-24 hours / >24 hours). Delay to hospital was defined as a longer time for admission to hospital (i.e. > 24 hours). A self-reported history or current treatment for cardiovascular diseases and risk factors, smoking and alcohol was obtained from patients or their relatives by research nurses. Melbourne 6 Risk factors and management of risk factors were recorded by trained data collectors using a standardised questionnaire. Supporting data were collected from patients, relatives, medical records and treating doctor. Dementia, hypertension, peripheral vascular disease (PVD), prior transient ischemic attack (TIA), and prior myocardial infarction were defined as a known history. Diabetes was defined as either a known history or current presentation with fasting blood glucose ≥7.0 mmol/L. AF was defined as either a known history or current presentation confirmed on ECG. Smoking status was classified from self-report as current smoker, ex-smoker, or never smoked. Prestroke disability was recorded from self-report questionnaire using the Barthel Index. Perth 8 The presence of heart failure was based on clinical criteria that included 1 of the following: raised venous pressure, gallop cardiac rhythm, and crepitations at the lung bases. The presence of AF required confirmation by an ECG within 1 month of the onset of stroke. Premorbid levels of physical disability were based on self-report or proxy sources (caregivers or medical records for those patients who were deceased or disabled) with the modified Barthel Index and mRS. Orebro 9 A record of medical history was taken and logistic data regarding hospital treatment period and investigations were noted. Premorbid mRS was recorded from self-report questionnaire. Dijon 10 History of hypertension was defined as known hypertension in a patient's medical history (either self-reported or from medical notes) or when a patient was treated with anti-hypertensive agents. A history of AF, previous myocardial infarction, a history of TIA were recoded. Pre-stroke treatments by anticoagulants, antiplatelet agents and antihypertensive treatments were noted. Matão 15 Risk factors and management of risk factors were recorded by trained data collectors using a standardised questionnaire. Tartu 16 Stroke risk factors were recorded based on case history and clinical evaluations. History of disease was obtained from outpatients and hospital records, family and patients. BP was measured at admission. AF was confirmed by ECG. Myocardial infarction was confirmed by ECG or autopsy. Premorbid mRS was recorded from self-report questionnaire. Bold denotes statistically significant differences between men and women; IS, Ischemic stroke; ICH, intracerebral hemorrhage; † among hospitalized patients National Institutes of Health Stroke Scale=NIHSS; Bold denotes statistically significant differences between men and women *RR was pooled using log-binominal regression with random-effects Race, marital status, education, age †, hypertension, AF, IHD, PVD, TIA, smoking, alcohol, hospital admission Tartu   16 Stroke subtype, hypertension, AF, IHD, TIA, hospital admission, delay to hospital, pre-stroke medication (antihypertensives, antiplatelets) AF, Atrial fibrillation; BMI, body mass index; IHD, ischaemic heart disease; mRS, modified Rankin scale; NIHSS, National Institutes of Health Stroke Scale; PVD, peripheral vascular disease, TIA, transient ischemic attack; SEP, socioeconomic position. * Not meeting all 4 criteria (missing <20% of cases, associated with sex, associated with stroke severity, and the inclusion of the covariate changed the magnitude of the sex coefficient by ≥10%) but to be included in the final multivariable model Bold denotes statistically significant differences between men and women; NIHSS, National Institutes of Health Stroke Scale; P H , P-value of heterogeneity; RR (95% CI), relative risk (95% confidence interval) of having more severe stroke (NIHSS>7) for women compared to men *List of covariates were demonstrated in main Table 2 . Figure S1 . Distribution of the National Institutes of Health Stroke Scale (NIHSS) scores by sex among those with stroke (both ischemic and intracerebral hemorrhagic stroke) in each study.
More severe stroke was defined as National Institutes of Health Stroke Scale >7. Figure S2 . Difference in stroke severity between women and men with ischemic stroke: unadjusted (top) and adjusted (bottom) random-effects meta-analyses among 6 studies.
More severe stroke was defined as National Institutes of Health Stroke Scale >7. Figure S3 . Difference in stroke severity between women and men with intracerebral haemorrhage (ICH): unadjusted (top) and adjusted (bottom) random-effects metaanalyses among 6 studies.
